{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:57Z","timestamp":1786984317485,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008682","name":"Boston VA Research Institute","doi-asserted-by":"publisher","award":["T32HP10251"],"award-info":[{"award-number":["T32HP10251"]}],"id":[{"id":"10.13039\/100008682","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012462","name":"Office of Academic Affiliations, Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.amepre.2017.10.015","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T09:06:22Z","timestamp":1512983182000},"page":"221-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation"],"prefix":"10.1016","volume":"54","author":[{"given":"Leland E.","family":"Hull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.amepre.2017.10.015_bib1","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","article-title":"BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer","volume":"336","author":"Couch","year":"1997","journal-title":"N Engl J Med"},{"issue":"1\u20133","key":"10.1016\/j.amepre.2017.10.015_bib2","first-page":"89","article-title":"Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2. Dis Markers","volume":"15","author":"Frank","year":"1999"},{"issue":"5","key":"10.1016\/j.amepre.2017.10.015_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1503523","article-title":"The role of risk-reducing surgery in hereditary breast and ovarian cancer","volume":"374","author":"Hartmann","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amepre.2017.10.015_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amepre.2017.10.015_bib5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.amepre.2017.10.015_bib6","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.amepre.2017.10.015_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.amepre.2017.10.015_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10549-009-0494-y","article-title":"A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer","volume":"121","author":"Diez","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.amepre.2017.10.015_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2350-12-134","article-title":"A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer","volume":"12","author":"Garcia-Casado","year":"2011","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.amepre.2017.10.015_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2350-9-58","article-title":"Novel de novo BRCA2 mutation in a patient with a family history of breast cancer","volume":"9","author":"Hansen","year":"2008","journal-title":"BMC Med Genet"},{"issue":"5","key":"10.1016\/j.amepre.2017.10.015_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1399-0004.2009.01246.x","article-title":"Case report: de novo BRCA2 gene mutation in a 35-year-old woman with breast cancer","volume":"76","author":"Marshall","year":"2009","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.amepre.2017.10.015_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jmg.38.2.102","article-title":"De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer","volume":"38","author":"van der Luijt","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.amepre.2017.10.015_bib13","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/ejhg.2016.93","article-title":"The biological effects and clinical implications of BRCA mutations: where do we go from here?","volume":"24","author":"Stoppa-Lyonnet","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.amepre.2017.10.015_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2296-11-45","article-title":"Primary care physicians\u2019 use of family history for cancer risk assessment","volume":"11","author":"Flynn","year":"2010","journal-title":"BMC Fam Pract"},{"issue":"3","key":"10.1016\/j.amepre.2017.10.015_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1525-1497.2004.30401.x","article-title":"Reconsidering the family history in primary care","volume":"19","author":"Rich","year":"2004","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.amepre.2017.10.015_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/fampra\/cmn053","article-title":"Interviews with primary care physicians regarding taking and interpreting the cancer family history","volume":"25","author":"Wood","year":"2008","journal-title":"Fam Pract"},{"issue":"44","key":"10.1016\/j.amepre.2017.10.015_bib17","first-page":"1044","article-title":"of family health history as a risk factor for disease\u2014United States, 2004","volume":"53","author":"Awareness","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.amepre.2017.10.015_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.amepre.2006.05.002","article-title":"Paternal relatives and family history of breast cancer","volume":"31","author":"Quillin","year":"2006","journal-title":"Am J Prev Med"},{"issue":"4","key":"10.1016\/j.amepre.2017.10.015_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"on behalf of USPSTF. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force Recommendation Statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amepre.2017.10.015_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1471-2407-9-283","article-title":"Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care","volume":"9","author":"Ashton-Prolla","year":"2009","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.amepre.2017.10.015_bib21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/GIM.0b013e3181b9b04a","article-title":"Evaluation of a breast\/ovarian cancer genetics referral screening tool in a mammography population","volume":"11","author":"Bellcross","year":"2009","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.amepre.2017.10.015_bib22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jmg.2003.017996","article-title":"A new scoring system for the chances of identifying a BRCA1\/2 mutation outperforms existing models including BRCAPRO","volume":"41","author":"Evans","year":"2004","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.amepre.2017.10.015_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1399-0004.2000.580408.x","article-title":"A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center","volume":"58","author":"Gilpin","year":"2000","journal-title":"Clin Genet"},{"issue":"8","key":"10.1016\/j.amepre.2017.10.015_bib24","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/cncr.22202","article-title":"Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening","volume":"107","author":"Hoskins","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.amepre.2017.10.015_bib25","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1055-9965.EPI-12-1280","article-title":"Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral","volume":"22","author":"Bellcross","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.amepre.2017.10.015_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s11606-010-1334-9","article-title":"Familial risk of cancer and knowledge and use of genetic testing","volume":"25","author":"Baer","year":"2010","journal-title":"J Gen Intern Med"},{"issue":"7","key":"10.1016\/j.amepre.2017.10.015_bib27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s11606-009-1009-6","article-title":"Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization","volume":"24","author":"Levy","year":"2009","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amepre.2017.10.015_bib28","series-title":"Survey Description, National Health Interview Survey, 2015","year":"2016"},{"key":"10.1016\/j.amepre.2017.10.015_bib29","unstructured":"National Center for Health Statistics. National Health Interview Survey, 2015. Public-use data file and documentation. www.cdc.gov\/nchs\/nhis\/quest_data_related_1997_forward.htm. Accessed November 7, 2016."},{"issue":"5","key":"10.1016\/j.amepre.2017.10.015_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amepre.2014.01.002","article-title":"Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys","volume":"46","author":"Mai","year":"2014","journal-title":"Am J Prev Med"},{"issue":"4","key":"10.1016\/j.amepre.2017.10.015_bib31","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome","volume":"113","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amepre.2017.10.015_bib32","series-title":"PDQ Genetics of Breast and Gynecologic Cancers","year":"2016"},{"issue":"1","key":"10.1016\/j.amepre.2017.10.015_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gim.2014.68","article-title":"Characteristics associated with genetic counseling referral and BRCA1\/2 testing among women in a large integrated health system","volume":"17","author":"Bellcross","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.amepre.2017.10.015_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/01.GIM.0000056829.76915.2A","article-title":"Early adoption of BRCA1\/2 testing: who and why","volume":"5","author":"Armstrong","year":"2003","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.amepre.2017.10.015_bib35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/GIM.0b013e3182091ba4","article-title":"Underutilization of BRCA1\/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk","volume":"13","author":"Levy","year":"2011","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.amepre.2017.10.015_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/ejhg.2014.180","article-title":"A systematic review of factors that act as barriers to patient referral to genetic services","volume":"23","author":"Delikurt","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"15","key":"10.1016\/j.amepre.2017.10.015_bib37","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.amepre.2017.10.015_bib38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3122\/jabfm.2009.03.080153","article-title":"Diffusion of breast cancer risk assessment in primary care","volume":"22","author":"Guerra","year":"2009","journal-title":"J Am Board Fam Med"},{"issue":"3","key":"10.1016\/j.amepre.2017.10.015_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ajmg.a.32643","article-title":"Genetic assessment of breast cancer risk in primary care practice","volume":"149A","author":"Burke","year":"2009","journal-title":"Am J Med Genet A"},{"issue":"5","key":"10.1016\/j.amepre.2017.10.015_bib40","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11606-014-2768-2","article-title":"Accuracy of ovarian and colon cancer risk assessments by U.S. physicians","volume":"29","author":"Baldwin","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"23","key":"10.1016\/j.amepre.2017.10.015_bib41","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1002\/cncr.26166","article-title":"Reported referral for genetic counseling or BRCA 1\/2 testing among United States physicians: a vignette-based study","volume":"117","author":"Trivers","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.amepre.2017.10.015_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrclinonc.2014.3","article-title":"Bilateral breast cancers","volume":"11","author":"Narod","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.amepre.2017.10.015_bib43","unstructured":"SEER Cancer Stat Facts: Ovarian Cancer. Bethesda, MD: National Cancer Institute. http:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html. Accessed April 12, 2017."},{"issue":"5","key":"10.1016\/j.amepre.2017.10.015_bib44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jama.2016.16918","article-title":"Genetic testing and counseling among patients with newly diagnosed breast cancer","volume":"317","author":"Kurian","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.amepre.2017.10.015_bib45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/oxfordjournals.aje.a009259","article-title":"Comparison of self-reported and database-linked family history of cancer data in a case-control study","volume":"146","author":"Kerber","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.amepre.2017.10.015_bib46","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jnci\/djr114","article-title":"Confirmation of family cancer history reported in a population-based survey","volume":"103","author":"Mai","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.amepre.2017.10.015_bib47","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jama.292.12.1480","article-title":"Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history","volume":"292","author":"Murff","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amepre.2017.10.015_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0749-3797(02)00593-7","article-title":"Validation of family history data in cancer family registries","volume":"24","author":"Ziogas","year":"2003","journal-title":"Am J Prev Med"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379717306384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379717306384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:50:38Z","timestamp":1760082638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379717306384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0749379717306384"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2017.10.015","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2017.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine","name":"copyright","label":"Copyright"}]}}